Phenethyl Cinnamate

Phenethyl Cinnamate

SCHEMBL43632

O=C(/C=C/c1ccccc1)OCCc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 6/20 1.00
AKR1B1 P15121 6/20 1.00
MAOB P27338 1/20 0.83
TTR P02766 4/20 0.72
ALOX5 P09917 3/20 0.72
APP P05067 2/20 0.72
CYP3A4 P08684 2/20 0.72
ALOX15 P16050 2/20 0.72
ALOX12 P18054 2/20 0.72
MAPK1 P28482 2/20 0.72
HSD17B10 Q99714 2/20 0.72
LMNA P02545 2/20 0.72
KDM4E B2RXH2 1/20 0.72
MEN1 O00255 1/20 0.72
GMNN O75496 1/20 0.72
ALDH1A1 P00352 1/20 0.72
EGFR P00533 1/20 0.72
ESR1 P03372 1/20 0.72
ERBB2 P04626 1/20 0.72
LCK P06239 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenethyl Cinnamate SCHEMBL4351248 1.00 AKR1B10 (1.00) AKR1B10AKR1B1MAOBTTRALOX5
Phenethyl Cinnamate SCHEMBL43631 1.00 AKR1B10 (1.00) AKR1B10AKR1B1MAOBTTRALOX5
Phenethyl Cinnamate SCHEMBL28334047 0.95 AKR1B10 (0.91) AKR1B10AKR1B1MAOBTTRALOX5
Phenethyl Cinnamate SCHEMBL28202159 0.91 AKR1B10 (0.83) AKR1B10AKR1B1MAOBTTRALOX5
SCHEMBL19279512 0.91 AKR1B10 (0.83) AKR1B10AKR1B1MAOBTTRALOX5
SCHEMBL9277968 0.91 AKR1B10 (0.83) AKR1B10AKR1B1MAOBTTRALOX5
SCHEMBL16234738 0.91 AKR1B10 (0.83) AKR1B10AKR1B1MAOBTTRALOX5
SCHEMBL7377864 0.91 AKR1B10 (1.00) AKR1B10AKR1B1MAOBTTRALOX5
SCHEMBL7377862 0.91 AKR1B10 (1.00) AKR1B10AKR1B1MAOBTTRALOX5
SCHEMBL3249348 0.90 AKR1B10 (0.84) AKR1B10AKR1B1MAOBTTRALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4302747-B1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT OREAL (FR) 2026-01-14 EP claimed
EP-4618965-A1 NOVEL OPHTHALMIC FORMULATION Fertis India Pvt. Ltd. (IN) 2025-09-24 EP claimed
CN-119859323-A Odor-free environment-friendly microcapsule, odor-free environment-friendly asphalt additive and preparation method thereof 中国石油化工股份有限公司 2025-04-22 CN claimed
CN-119859033-A Odor-free environment-friendly sand-containing fog sealing layer and preparation method thereof 中国石油化工股份有限公司 2025-04-22 CN claimed
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 WO claimed
WO-2025045354-A1 A FRAGRANCE TABLET SYMRISE AG (DE) 2025-03-06 WO claimed
WO-2025045353-A1 A FRAGRANCE POD SYMRISE AG (DE) 2025-03-06 WO claimed
WO-2025043867-A1 ASPHALT ADDITIVE, AND ASPHALT COMPOSITION AND PREPARATION METHOD THEREFOR 中国石油化工股份有限公司 2025-03-06 WO claimed
WO-2025043864-A1 MICROCAPSULE, PREPARATION METHOD THEREFOR, AND USE THEREOF 中国石油化工股份有限公司 2025-03-06 WO claimed
CN-119552420-A Asphalt additive, asphalt composition and preparation method thereof 中国石油化工股份有限公司 2025-03-04 CN claimed
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
US-20050136021-A1 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
WO-2005025523-A2 ANTIPERSPIRANT CLEAR GEL WITH LOW GLYCOL CONTENT COLGATE-PALMOLIVE COMPANY (US) 2005-03-24 WO claimed
US-6858575-B2 Pro-perfume compositions and substrate-treating products and methods using them PROCTER & GAMBLE COMPANY (US) 2005-02-22 US claimed
EP-1448757-A1 PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2004-08-25 EP claimed
CN-1481351-A Malodor counteractant composition ����µ��ɷ����޹�˾ 2004-03-10 CN claimed
US-20030171250-A1 Pro-perfume compositions and substrate-treating products and methods using them THE PROCTER & GAMBLE COMPANY 2003-09-11 US claimed
WO-2003046118-A1 PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2003-06-05 WO claimed
EP-1314777-A1 Pro-perfume compositions used in cleaning or fabric treatment products THE PROCTER & GAMBLE COMPANY (US) 2003-05-28 EP claimed
WO-2002098966-A2 AROMATIC PRINCIPLES FOR IMPROVING THE STABILITY IN STORAGE AND/OR FOR IMPROVING THE SOLUBILITY OF POLYVINYL ALCOHOLS AND/OR POLYVINYL ALCOHOLS WITH BONDED CELLULOSE DROM FRAGRANCES INTERNATIONAL KG (DE) 2002-12-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients F9, RPL39, ECPAS AKR1B10 134/4885AKR1B1 194/4885MAOB 1322/4885
US-20050136021-A1 Active-releasing cyclic siloxanes F9, RPL39, ALDH16A1 AKR1B10 94/4885AKR1B1 134/4885MAOB 1389/4885
US-20030171250-A1 Pro-perfume compositions and substrate-treating products and methods using them FASN, ALOX5, PAM AKR1B10 1632/4885AKR1B1 1191/4885MAOB 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.